193 related articles for article (PubMed ID: 28220208)
1. ABCB4 missense mutations D243A, K435T, G535D, I490T, R545C, and S978P significantly impair the lipid floppase and likely predispose to secondary pathologies in the human population.
Andress EJ; Nicolaou M; McGeoghan F; Linton KJ
Cell Mol Life Sci; 2017 Jul; 74(13):2513-2524. PubMed ID: 28220208
[TBL] [Abstract][Full Text] [Related]
2. Complementary functions of the flippase ATP8B1 and the floppase ABCB4 in maintaining canalicular membrane integrity.
Groen A; Romero MR; Kunne C; Hoosdally SJ; Dixon PH; Wooding C; Williamson C; Seppen J; Van den Oever K; Mok KS; Paulusma CC; Linton KJ; Oude Elferink RP
Gastroenterology; 2011 Nov; 141(5):1927-37.e1-4. PubMed ID: 21820390
[TBL] [Abstract][Full Text] [Related]
3. ABCB4/MDR3 in health and disease - at the crossroads of biochemistry and medicine.
Prescher M; Kroll T; Schmitt L
Biol Chem; 2019 Sep; 400(10):1245-1259. PubMed ID: 30730833
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4.
Andress EJ; Nicolaou M; Romero MR; Naik S; Dixon PH; Williamson C; Linton KJ
Hepatology; 2014 May; 59(5):1921-31. PubMed ID: 24806754
[TBL] [Abstract][Full Text] [Related]
5. Detergent screening and purification of the human liver ABC transporters BSEP (ABCB11) and MDR3 (ABCB4) expressed in the yeast Pichia pastoris.
Ellinger P; Kluth M; Stindt J; Smits SH; Schmitt L
PLoS One; 2013; 8(4):e60620. PubMed ID: 23593265
[TBL] [Abstract][Full Text] [Related]
6. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).
Oude Elferink RP; Paulusma CC
Pflugers Arch; 2007 Feb; 453(5):601-10. PubMed ID: 16622704
[TBL] [Abstract][Full Text] [Related]
7. Expression Analysis of ATP-Binding Cassette Transporters ABCB11 and ABCB4 in Primary Sclerosing Cholangitis and Variety of Pediatric and Adult Cholestatic and Noncholestatic Liver Diseases.
Thoeni C; Waldherr R; Scheuerer J; Schmitteckert S; Roeth R; Niesler B; Cutz E; Flechtenmacher C; Goeppert B; Schirmacher P; Lasitschka F
Can J Gastroenterol Hepatol; 2019; 2019():1085717. PubMed ID: 31886153
[TBL] [Abstract][Full Text] [Related]
8. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
Dröge C; Bonus M; Baumann U; Klindt C; Lainka E; Kathemann S; Brinkert F; Grabhorn E; Pfister ED; Wenning D; Fichtner A; Gotthardt DN; Weiss KH; McKiernan P; Puri RD; Verma IC; Kluge S; Gohlke H; Schmitt L; Kubitz R; Häussinger D; Keitel V
J Hepatol; 2017 Dec; 67(6):1253-1264. PubMed ID: 28733223
[TBL] [Abstract][Full Text] [Related]
9. A mutation within the extended X loop abolished substrate-induced ATPase activity of the human liver ATP-binding cassette (ABC) transporter MDR3.
Kluth M; Stindt J; Dröge C; Linnemann D; Kubitz R; Schmitt L
J Biol Chem; 2015 Feb; 290(8):4896-4907. PubMed ID: 25533467
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of ABCB4/MDR3 ATPase activity requires an intact phosphatidylcholine lipid.
Prescher M; Smits SHJ; Schmitt L
J Lipid Res; 2020 Dec; 61(12):1605-1616. PubMed ID: 32917728
[TBL] [Abstract][Full Text] [Related]
11. Lipid flopping in the liver.
Linton KJ
Biochem Soc Trans; 2015 Oct; 43(5):1003-10. PubMed ID: 26517915
[TBL] [Abstract][Full Text] [Related]
12. Effects of cellular, chemical, and pharmacological chaperones on the rescue of a trafficking-defective mutant of the ATP-binding cassette transporter proteins ABCB1/ABCB4.
Gautherot J; Durand-Schneider AM; Delautier D; Delaunay JL; Rada A; Gabillet J; Housset C; Maurice M; Aït-Slimane T
J Biol Chem; 2012 Feb; 287(7):5070-8. PubMed ID: 22184139
[TBL] [Abstract][Full Text] [Related]
13. [Mechanism of Taurohyodeoxycholate-induced Biliary Phospholipid Efflux -Understanding the Function of the ABCB4 Enhancer for Developing Therapeutic Agents against Bile Salt-induced Liver Injury].
Ikeda Y
Yakugaku Zasshi; 2020; 140(11):1329-1334. PubMed ID: 33132268
[TBL] [Abstract][Full Text] [Related]
14. RAB10 Interacts with ABCB4 and Regulates Its Intracellular Traffic.
Ben Saad A; Vauthier V; Lapalus M; Mareux E; Bennana E; Durand-Schneider AM; Bruneau A; Delaunay JL; Gonzales E; Housset C; Aït-Slimane T; Guillonneau F; Jacquemin E; Falguières T
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209301
[TBL] [Abstract][Full Text] [Related]
15. Canalicular ABC transporters and liver disease.
Nicolaou M; Andress EJ; Zolnerciks JK; Dixon PH; Williamson C; Linton KJ
J Pathol; 2012 Jan; 226(2):300-15. PubMed ID: 21984474
[TBL] [Abstract][Full Text] [Related]
16. ABCB4 disease: Many faces of one gene deficiency.
Sticova E; Jirsa M
Ann Hepatol; 2020; 19(2):126-133. PubMed ID: 31759867
[TBL] [Abstract][Full Text] [Related]
17. Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).
Lang T; Haberl M; Jung D; Drescher A; Schlagenhaufer R; Keil A; Mornhinweg E; Stieger B; Kullak-Ublick GA; Kerb R
Drug Metab Dispos; 2006 Sep; 34(9):1582-99. PubMed ID: 16763017
[TBL] [Abstract][Full Text] [Related]
18. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
Reichert MC; Lammert F
Semin Liver Dis; 2018 Nov; 38(4):299-307. PubMed ID: 30357767
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts.
Morita SY; Terada T
Biomed Res Int; 2014; 2014():954781. PubMed ID: 25133187
[TBL] [Abstract][Full Text] [Related]
20. Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury.
Lang C; Meier Y; Stieger B; Beuers U; Lang T; Kerb R; Kullak-Ublick GA; Meier PJ; Pauli-Magnus C
Pharmacogenet Genomics; 2007 Jan; 17(1):47-60. PubMed ID: 17264802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]